Hide metadata

Cost-Effectiveness of Tenofovir Alafenamide (TAF) compared to Entecavir (ETV) and Tenofovir Disoproxil Fumarate (TDF) for Treatment of Hepatitis B e Antigen-Positive Chronic Hepatitis B in China

dc.contributor.authorXu, Sang
dc.date.accessioned2020-10-06T23:52:37Z
dc.date.available2020-10-06T23:52:37Z
dc.date.issued2020
dc.identifier.citationXu, Sang. Cost-Effectiveness of Tenofovir Alafenamide (TAF) compared to Entecavir (ETV) and Tenofovir Disoproxil Fumarate (TDF) for Treatment of Hepatitis B e Antigen-Positive Chronic Hepatitis B in China. Master thesis, University of Oslo, 2020
dc.identifier.urihttp://hdl.handle.net/10852/80445
dc.description.abstracteng
dc.language.isoeng
dc.subject
dc.titleCost-Effectiveness of Tenofovir Alafenamide (TAF) compared to Entecavir (ETV) and Tenofovir Disoproxil Fumarate (TDF) for Treatment of Hepatitis B e Antigen-Positive Chronic Hepatitis B in Chinaeng
dc.typeMaster thesis
dc.date.updated2020-10-07T23:49:43Z
dc.creator.authorXu, Sang
dc.identifier.urnURN:NBN:no-83379
dc.type.documentMasteroppgave
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/80445/1/Master_Thesis_Sang_Xu.pdf


Files in this item

Name:
Master_Thesis_Sang_Xu.pdf
Size:
1.624Mb
Format:
application/
View/Open

Appears in the following Collection

Hide metadata